Windtree Therapeutics, Inc. in brief
Windtree Therapeutics, Inc. is a listed company in the Biotechnology industry, based in California, USA. It was founded in 1992. Its last known market value was $3 M (January 2024); there is no current figure. Its shares trade under the symbol WINT (Nasdaq).
Written from the figures on this page, so it changes when they do. Dates and sources are under Sources and freshness.
Windtree Therapeutics, Inc. timeline
- 1992
- 🏁· approximateFounded
Events of Windtree Therapeutics, Inc. from the company record. Dates marked approximate come from statements without a cited source. Spotted a mistake? Use the correction form below.
Market cap history
World rank over time
Rank in USA: #3,498 (Jan 2020) · #3,766 (Jan 2021) · #5,036 (Jan 2022) · #5,674 (Dec 2022) · #5,533 (Jul 2023) · #4,685 (Jan 2024)
Markets and events: Windtree Therapeutics, Inc.#
Short interest, dividends, buybacks, splits, index changes and other events from FINRA, the SEC and the exchanges.
Trading halts
- 2025-02-21 00:50 UTC, code T3, resumed 14:00 UTC
Fails to deliver
- : 69 shares
- : 19 shares
- : 1 shares at $0.01
- : 581 shares at $0.02
- : 581 shares at $0.02
Source: FINRA, SEC EDGAR (8-K, S-1/F-1, 424B4, XBRL, fails-to-deliver), Nasdaq Trader, Wikipedia index change tables
H-1B hiring at Windtree Therapeutics, Inc.#
1 labor condition applications certified in fiscal 2021 for 1 positions, at a median wage of $95 K a year.
| Job title | Positions | Median wage offered |
|---|---|---|
| Biostatistician IIBiostatisticians | 1 | $95 K |
Where: Warrington, PA 1
Source: US Department of Labor, LCA disclosure data. An application is not a visa: USCIS decides each petition later, and the yearly lottery limits new H-1B visas. Filed as Windtree Therapeutics, Inc.
Peer comparison · Biotechnology
| Company | Market cap | P/E | Net margin | Rev. growth |
|---|---|---|---|---|
| Windtree Therapeutics, Inc.🇺🇸 | $3 M | — | — | — |
| Novo Nordisk A/S🇩🇰 | $203.2 B | 13.1× | 33.1% | +10.8% |
| Vertex Pharmaceuticals Incorporated🇺🇸 | $134.3 B | 33.8× | 30.7% | +8.9% |
| Moderna, Inc.🇺🇸 | $90.1 B | — | -110.5% | -39.9% |
| Regeneron Pharmaceuticals, Inc.🇺🇸 | $84.1 B | 17.5× | 28.5% | +1.0% |
| Argenx SE🇳🇱 | $52.8 B | 40.9× | 31.1% | +89.9% |
| CSL Limited🇦🇺 | $51.6 B | — | -16.4% | — |
| Samsung Biologics Co., Ltd.🇰🇷 | $51.5 B | 40.5× | 39.2% | — |
| UCB SA🇧🇪 | $48.6 B | 26.3× | 20.1% | +31.1% |
P/E and margins use trailing 12-month results where available; growth is the latest fiscal year.
Questions, comparisons and similar companies#
Compare head to head
Similar companies by size and industry
- Novo Nordisk A/S$203.2 B
- Vertex Pharmaceuticals Incorporated$134.3 B
- Moderna, Inc.$90.1 B
- Regeneron Pharmaceuticals, Inc.$84.1 B
- Argenx SE$52.8 B
- CSL Limited$51.6 B
Sources and freshness
- Market cap:
- Jan 5, 2024 (last known)
- Profile updated:
- Nov 4, 2026
Figures from value.today research.
How each figure is collected: data sources and methodology. Market caps in US dollars unless you switch the currency.
Work at Windtree Therapeutics, Inc.? Verify and update this profile — free
Show Windtree Therapeutics, Inc.'s ranking on your website Get the badge
The badge updates itself as the ranking changes.